Stock listing
DRMA Stock Price, News, Filings & Events — Dermata Therapeutics, Inc.
Selected listing: DRMA · NASDAQ · USD · US
This page tracks Dermata Therapeutics, Inc.'s DRMA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DRMA:NASDAQ. DRMA:NASDAQ is the stock-level entry point for investors researching Dermata Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dermata Therapeutics, Inc. (ticker: DRMA) is a publicly traded company in the American market with a market capitalization of approximately $5.3 million. The company focuses on developing innovative therapies for skin conditions. Dermata aims to address unmet needs in dermatology through its research and development efforts.
- Ticker
- DRMA:NASDAQ
- Asset type
- Stock
- Market cap
- $5.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Dermata Therapeutics, Inc. DRMA:NASDAQ stock context
This page tracks Dermata Therapeutics, Inc.'s DRMA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DRMA:NASDAQ. DRMA:NASDAQ is the stock-level entry point for investors researching Dermata Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dermata Therapeutics, Inc. (ticker: DRMA) is a publicly traded company in the American market with a market capitalization of approximately $5.3 million. The company focuses on developing innovative therapies for skin conditions. Dermata aims to address unmet needs in dermatology through its research and development efforts.
Research Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for DRMA:NASDAQ.
Dermata Therapeutics, Inc. company profile
View the public company page for Dermata Therapeutics, Inc. on 6ix.
Dermata Therapeutics, Inc. news
Read company news and market updates connected to Dermata Therapeutics, Inc..
Dermata Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Dermata Therapeutics, Inc..